title: [Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey].
abstract: OBJECTIVE
  To assess information that general practitioners had on hepatitis C and on the hepatitis C network in hospitals and private practice.
  
  
  METHODS
  A national telephone survey of 604 general practitioners was conducted between March 18 and 23, 1998.
  
  
  RESULTS
  Screening and management of hepatitis C was important for 89% and 97% of general practitioners. Screening was performed in relation to the relative risk (IV drug users 89%, blood transfusion before 1991 88%). General practitioners wanted more information on treatment (54%), patient counselling (42%) and the potential risks of the disease (42%). Of 604 general practitioners, 6% were involved in a hepatitis C network, while 21% were involved in another network (drug users 9%, AIDS 8%). Of the 94% general practitioners who were not part of the network, 33% were willing to join a hepatitis C network. Only 56% were aware of a hepatitis C network (press article 30%, mailing 17% or local meeting 12%). The difficulties for the involvement of general practitioners were: lack of time, topics not adapted to daily practice and geographic constraints (74%), too few patients in their practice (52%), no need (38%), the idea itself of a network and lack of information (28%).
  
  
  CONCLUSIONS
  General practitioners screen patients at risk of hepatitis C. They want to be better informed about treatment, patient counselling, and the potential risks of hepatitis C. They are less involved in hepatitis C networks than in other networks (drug, AIDS). However, one third of general practitioners would like to be involved in a hepatitis C network. These results could be useful for implementing post-graduate courses and general practitioner training.
authors.affiliation: Produits Roche, Neuilly-sur-Seine; Service d'Hépato-Gastroentérologie, Hôpital Saint-Joseph, Marseille; Taylor Nelson SOFRES Healthcare; Services d'Hépato-Gastoentérologie, Centre Hospitalie.
authors.forename: G
authors.initials: G
authors.lastname: Babany
authors.forename: M
authors.initials: M
authors.lastname: Bourlière
authors.forename: H
authors.initials: H
authors.lastname: Chevalier
authors.forename: M
authors.initials: M
authors.lastname: Chousterman
authors.forename: P
authors.initials: P
authors.lastname: Couzigou
authors.forename: H
authors.initials: H
authors.lastname: Desmorat
authors.forename: D
authors.initials: D
authors.lastname: Dhumeaux
authors.forename: M
authors.initials: M
authors.lastname: Doffoël
authors.forename: J
authors.initials: J
authors.lastname: Gournay
authors.forename: D
authors.initials: D
authors.lastname: Loiseau
authors.forename: P
authors.initials: P
authors.lastname: Mercet
authors.forename: J
authors.initials: J
authors.lastname: Moussalli
authors.forename: C
authors.initials: C
authors.lastname: Trépo
authors.forename: G
authors.initials: G
authors.lastname: Tucat
authors.forename: D
authors.initials: D
authors.lastname: Doan Tran
authors.forename: M F
authors.initials: MF
authors.lastname: Saint-Marc-Girardin
mesh_terms: D000328:Adult; D005194:Family Practice; D005260:Female; D005602:France; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D012307:Risk Factors